SIG
Sargent Investment Group Portfolio holdings
AUM
$740M
This Quarter Return
+11.19%
1 Year Return
+41.44%
3 Year Return
+107.47%
5 Year Return
+182.16%
10 Year Return
–
AUM
$457M
AUM Growth
+$457M
(+10%)
Cap. Flow
+$2.79M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
38.22%
Holding
216
New
11
Increased
77
Reduced
90
Closed
6
Top Buys
| 1 |
SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
$6.68M |
| 2 |
Aspen Aerogels
ASPN
|
$1.03M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$968K |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
$811K |
| 5 |
Mastercard
MA
|
$786K |
Top Sells
| 1 |
Vanguard Mid-Cap Value ETF
VOE
|
$3.59M |
| 2 |
Ford
F
|
$1.83M |
| 3 |
Blackstone
BX
|
$1.08M |
| 4 |
Apple
AAPL
|
$909K |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$797K |
Sector Composition
| 1 | Technology | 26.55% |
| 2 | Financials | 12.34% |
| 3 | Healthcare | 7.77% |
| 4 | Industrials | 6.99% |
| 5 | Consumer Discretionary | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ardelyx
ARDX
$1.57B
| $123K | 0.03% |
19,819
-16,118
| -45% | -$99.9K |
|
|
RVNC
202
DELISTED
Revance Therapeutics, Inc.
RVNC
| $121K | 0.03% |
+13,822
| New | +$121K |
|
203
Novavax
NVAX
$1.2B
| $97.7K | 0.02% |
20,345
-4,900
| -19% | -$23.5K |
|
204
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $86.8K | 0.02% |
26,060
+6,368
| +32% | +$21.2K |
|
205
Assertio
ASRT
$78M
| $48K | 0.01% |
44,864
-35,682
| -44% | -$38.2K |
|
206
Athira Pharma
ATHA
$15.5M
| $44.2K | 0.01% |
18,204
-2,544
| -12% | -$6.18K |
|
|
BLUE
207
DELISTED
bluebird bio
BLUE
| $37.7K | 0.01% |
27,339
+3,015
| +12% | +$4.17K |
|
208
Summit Therapeutics
SMMT
$17.5B
| $26.1K | 0.01% |
10,000
| – | – |
|
|
TELL
209
DELISTED
Tellurian Inc.
TELL
| $11.3K | ﹤0.01% |
15,000
| – | – |
|
|
INTZ
210
DELISTED
INTRUSION INC NEW
INTZ
| $7.22K | ﹤0.01% |
28,555
-850
| -3% | -$215 |
|
|
CGRN
211
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| – | – |
-57,000
| Closed | -$40.4K |
|
|
KNTE
212
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| – | – |
-12,398
| Closed | -$17.4K |
|
213
Technology Select Sector SPDR Fund
XLK
$83.6B
| – | – |
-1,730
| Closed | -$284K |
|
214
Verizon
VZ
$184B
| – | – |
-7,256
| Closed | -$235K |
|
215
SiriusXM
SIRI
$7.92B
| – | – |
-12,500
| Closed | -$56.5K |
|
216
Relmada Therapeutics
RLMD
$48.8M
| – | – |
-16,206
| Closed | -$48.6K |
|